Critical issues in megatrials on new oral anticoagulants. Rocket AF: applying results to low risk patients
Submitted: November 25, 2015
Accepted: November 25, 2015
Published: November 25, 2015
Accepted: November 25, 2015
Abstract Views: 967
PDF: 546
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.